Human CD328/Siglec-7 DTSet enzyme-linked immunoassay kit

CAT: DSEH016305;DSEH016315 Datasheet
Specification 96*5 Test;96T*15 Test
Standard Curve Range 15.63 pg/ml-1000 pg/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 2
Sample Volume 50 μl
Type Not Ready-to-Use
Test Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0260 0.0248 0.0254
15.63 0.1868 0.1681 0.1775 0.1521
31.25 0.2963 0.2725 0.2844 0.2590
62.50 0.5450 0.5410 0.5430 0.5176
125.00 0.9443 1.0112 0.9778 0.9524
250.00 1.8356 2.0073 1.9215 1.8961
500.00 3.1206 3.3465 3.2336 3.2082
1000.00 4.3701 4.4261 4.3981 4.3727

Product Features

  • Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
  • Development protocols are provided to guide further assay optimization
  • Assay can be customized to your specific needs
  • Economical alternative to complete kits

Kit Content

  • Capture Antibody
  • Detection Antibody
  • Recombinant Standard
  • Streptavidin conjugated to horseradish-peroxidase (Streptavidin-HRP)

Other Reagents Required

DTSet Ancillary Reagent Kit (5 plates): containing 96 well microplates, plate sealers, substrate solution, stop solution, plate coating buffer (PBS), wash buffer, and assay buffer.

  • 96 well microplates: YOUKE Life, Catalog # DSEP01. Plate Sealers: YOUKE Life, Catalog # DSSF01.
  • Coating Buffer: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2-7.4, 0.2μm filtered . YOUKE Life, Catalog # DSCB01.
  • Blocking Buffer: YOUKE Life, Catalog # DSBB01.
  • Wash Buffer: 0.05% Tween® 20 in PBS, pH 7.2-7.4. YOUKE Life, Catalog # DSWB01.
  • Assay Buffer: 0.5% BSA,0.05% Tween® 20,PBS Solution.YOUKE Life, Catalog # DSAB01
  • Substrate Solution: Tetramethylbenzidine. YOUKE Life, Catalog # DSTS01.
  • Stop Solution: 0.5mol/ml H2SO4. YOUKE Life, Catalog # DSSS01.

Background: CD328/Siglec-7

Siglecs (sialic acid binding Ig-like lectins) are I-type (Ig-type) lectins belonging to the Ig superfamily. They are characterized by an N-terminal Ig-like V-type domain which mediates sialic acid binding, followed by varying numbers of Ig-like C2-type domains. Eleven human Siglecs have been cloned and characterized. They are sialoadhesin/CD169/Siglec-1, CD22/Siglec-2, CD33/Siglec-3, Myelin-Associated Glycoprotein (MAG/Siglec-4a) and Siglecs 5 to 11. To date, no Siglec has been shown to recognized any cell surface ligand other than sialic acids, suggesting that interactions with glycans containing this carbohydrate are important in mediating the biological functions of Siglecs. Siglecs 5 to 11 share a high degree of sequence similarity with CD33/Siglec-3 both in their extracellular and intracellular regions. They are collectively referred to as CD33-related Siglecs. One remarkable feature of the CD33-related Siglecs is their differential expression pattern within the hematopoietic system. This fact, together with the presence of two conserved immunoreceptor tyrosine-based inhibition motifs (ITIMs) in their cytoplasmic tails, suggests that CD33-related Siglecs are involved in the regulation of cellular activation within the immune system.

Human Siglec-7 encodes a 467 amino acid (aa) polypeptide with a hydrophobic signal peptide, an N-terminal Ig-like V-type domain, two Ig-like C2-type domains, a transmembrane region and a cytoplasmic tail. Siglec-7 exists as a monomer on the cell surface and is expressed on natural killer cells, CD8+ T cells and monocytes. It binds equally well to both alpha 2,3- and alpha 2,6-linked sialic acid. The gene encoding Siglec-7 was mapped to chromosome 19q13.3.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee